Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
⏰ React to the Market Faster with Custom, Real-Time News Get Started
Walmart to pay $215 million to settle Florida opioid claims
© Reuters. FILE PHOTO: The exterior of a Walmart department store is pictured in West Haven, Connecticut, U.S., February 17, 2021. REUTERS/Mike Segar/File Photo
By Brendan Pierson
(Reuters) -Walmart Inc has agreed to pay $215 million to resolve claims its pharmacies fueled an epidemic of opioid addiction in Florida, the state's attorney general announced on Thursday.
As part of the deal, Walmart (NYSE:WMT) has also agreed to dispense 672,000 treatment kits with the anti-overdose drug naloxone to first responders in the state.
"I'm grateful for Walmart stepping up and agreeing to partner with the state to provide law enforcement and first responders with much-needed naloxone," Attorney General Ashley Moody said in a statement. "This will greatly help in our continuing mission to end the opioid crisis and save lives."
The state has now secured a total of $3.2 billion through legal action to help fight the opioid crisis, according to Moody's (NYSE:MCO) office. That includes recent settlements of $683 million with Walgreens Boots Alliance (NASDAQ:WBA), $484 million with CVS Health Corp (NYSE:CVS) and a combined $394 million with three drugmakers.
"This partnership is the latest chapter in Walmart's commitment to fight the opioid crisis," Walmart spokesperson Randy Hargrove said in a statement.
The retailer, which did not admit any wrongdoing, previously settled opioid-related claims brought by West Virginia for $65 million and New Mexico for an undisclosed sum. It was also ordered in August to pay a combined $650.6 million with Walgreens and CVS to two Ohio counties.
The U.S. opioid crisis has caused more than 500,000 overdose deaths over two decades, according to federal government data. More than 3,300 lawsuits have been filed accusing drugmakers, distributors and pharmacy chains of fueling the crisis.
Major drugmakers and distributors have reached nationwide settlements worth more than $30 billion altogether, resolving most lawsuits against them, while pharmacy operators have continued to litigate or settle cases one by one.
Related Articles
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.